期刊文献+

多西紫杉醇纳米脂质体的制备及性质考察 被引量:1

Preparation and characterization of docetaxel nanoliposomes
下载PDF
导出
摘要 目的制备多西紫杉醇纳米脂质体,并考察其理化性质和体外释药行为。方法采用薄膜分散-高压均质法制备多西紫杉醇纳米脂质体,单因素考察法优化处方。透射电镜观察脂质体的形态,动态激光散射法测定粒径分布、Zeta电位,反透析法测定包封率,动态膜透析法考察体外释药行为。结果最佳处方为:药脂比1∶15,胆固醇、磷脂质量比1∶8,有机相/水相比例为5∶1。优化条件下制备的多西紫杉醇脂质体的粒径为(200.3±3.7)nm,Zeta电位-15.10 m V,包封率为(90.76±1.42)﹪,体外释放符合Higuchi方程。结论制备的多西紫杉醇脂质体粒径均匀、包封率高,优化的处方工艺可行。 Objective: OBJECTIVE To prepare docetaxel nanoliposomes and investigate their physico-chemical properties and release profile in vitro. Methods: Docetaxel liposomes were prepared by film dispersion-high pressure homogenization technology. The formulation was optimized using single factor screening. Transmission electron microscopy was used to study the shape. The diameter and Zeta potential was measured by dynamic light scattering. Retrodialysis method was used to determine the entrapment efficiency of the liposomes. In vitro drug release of the liposomes was investigated using dialysis method. Results: TS The optimized formulation was as follows: m( drug) ∶ m( lipids) = 1∶ 15,m( cholesterol) :m( soya lecithin) = 1 ∶ 8,organic phase / aqueous solution ratio was 5 ∶ 1. The mean diameter of the liposomes was( 200. 3 ± 3. 7) nm with Zeta potential of-15. 10 m V,and the entrapment efficiency was( 90. 76 ± 1. 42) ﹪. The in vitro drug release profile was fitted with Higuchi equation. Conclusion: The uniform nanoliposomes with high entrapment efficiency indicated the optimized formulation was feasible.
出处 《泰山医学院学报》 CAS 2015年第10期1096-1099,共4页 Journal of Taishan Medical College
基金 山东省高等学校科技计划项目(J13LM01)
关键词 多西紫杉醇 纳米脂质体 制备 体外释放 docetaxel nanoliposome preparation in vitro release
  • 相关文献

参考文献9

  • 1Hennenfent KL,Govindan R.Novel formulations of taxanes:a review.Old wine in a new bottle[J].Ann oncol.2006,17(5):735-749.
  • 2Liu B,Yang M,Li R,et al.The antitumor effect of novel docetaxel-loaded thermosensive micelles[J].Eur J Pharm Biopharm.2008,69(2):527-534.
  • 3张学农,张强.紫杉烷类新剂型的研究进展及其临床应用[J].国外医学(药学分册),2002,29(6):321-325. 被引量:25
  • 4Hwang HY,Kim IS,Kwon IC,et al.Tumor targetability and antitumor effect of docetaxel loaded hydrophobically modified glycol chitosan nanoparticles[J].J Control Release,2008,128(1):23-31.
  • 5颜琳,黄磊,张庆华.紫杉醇脂质体联合奈达铂治疗宫颈癌74例[J].医药导报,2013,32(9):1146-1148. 被引量:12
  • 6Immordino ML,Brusa P,Arpicco S,et al.Preparation,characterization,cytotoxicity and pharmaceutics of liposomes containing docetaxel[J].J Control Release,2003,91(3):417-429.
  • 7熊非,朱家壁,王维,华小兵.灯盏花素纳米脂质体包封率测定方法研究[J].药学学报,2004,39(9):755-757. 被引量:33
  • 8Langner M.Effect of liposome molecular composition on its ability to carry drugs[J].Pol J Pharmacol,2000,52(1):3-14.
  • 9Calvagno MG,Celia C,Paolino D,et al.Effects of lipid composition and preparation conditions on physical-chemical properties,technological parameters and in vitro biological activity of gemcitabine-loaded liposomes[J].Cur Drug Deliv,2007,4(1):89-101.

二级参考文献37

  • 1孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2010:153-156.
  • 2Kim SC, Kim DW, Shim YH, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy[J]. J Control Release, 2001, 72(1-3):191-202.
  • 3Campbell RB, Balasubramanian SV, Straubinger RM. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes[J]. J Pharm Sci, 2001, 90(8):1091-1105.
  • 4Dordunoo SK, Jackson JK, Arsenault LA, et al. Taxol encapsulation in poly(epsilon-caprolactone)microspheres[J].Cancer Chemother Pharmacol, 1995, 36(4):279-182.
  • 5Mu L, Feng SS. Fabrication, characterization, and in vitro release of paclitaxel (Taxol)loaded poly(lactic-co-glycolic acid)microspheres prepared by spray drying technique with lipid/cholesterol[J]. J Control Release, 2001, 76(3):239 - 254.
  • 6Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)[J]. J Control Release, 2002, 80(1-3):129-144.
  • 7Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres compsed of methoxy poly(ethylene glycol)and poly (epsilon-caprolactone)as novel anticancer drug carriers [J]. Biomaterials, 2001, 22(13):1697-1704.
  • 8Cavalli R, Caputo O, Casco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel [J]. Eur J Pharm Sci , 2000, 10(4):305-309.
  • 9Fromes Y, Gounon P, Veitia R, et al. Influence of microtubule-associated proteins on the differential effects of paclitaxelanddocetaxel[J]. JProtein Chem, 1996, 15(4):377-388.
  • 10Miglietta A, Bocca C, Gabriel L. Comparative studies on biological activity of certain microtubule-interacting taxanes [J]. Chem BiolInteract, 2002, 139(3):283-299.

共引文献67

同被引文献21

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部